They had a body mass index (BMI) of at least 30 on the date of treatment initiation or during the latest available primary care visit, or a BMI of at least 27 with one or more weight-related comorbidities such as hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease
Important: Even though Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Victoza, and Trulicity appear on its site, the MEDvidi support team confirmed that they are not prescribing injectable GLP-1s or compounded versions at this time (Nov 17, 2025)
Upon receptor binding to hormones or agonist analogs, the cells produce and secrete SEAP in the supernatant
Patients with cystinuria, homocystinuria, or severe kidney disease should avoid supplementation without nephrologist oversight
That's the No